Biochemically Recurrent Prostate Carcinoma Clinical Trials

17 clinical trials for Biochemically Recurrent Prostate Carcinoma across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial — RECRUITING · PHASE2
• SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma — RECRUITING · PHASE3
• An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial — RECRUITING · PHASE1
• Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging — RECRUITING · PHASE3
• Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer — RECRUITING · PHASE2
• Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring — RECRUITING · PHASE2
• RElugolix VErsus LeUprolide Cardiac Trial — ACTIVE_NOT_RECRUITING · PHASE2
• An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study — COMPLETED · NA
• Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load — TERMINATED · PHASE2
• An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer — COMPLETED · PHASE1
• Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System — TERMINATED
• 68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer — COMPLETED · PHASE1
• 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy — TERMINATED · PHASE2
• 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer — COMPLETED · PHASE2
• Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study — WITHDRAWN · PHASE2

Refine this search